Verition Fund Management LLC Bristol Myers Squibb CO Transaction History

Verition Fund Management LLC

$21.7 Billion
Q3 2025

A detailed history of Verition Fund Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Verition Fund Management LLC holds 351,538 shares of BMY stock, worth $16.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

351,538

Previous 176,425 99.26%

Holding current value

$16.5 Million

Previous $8.17 Million 94.15%

% of portfolio

0.07%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.31 - $48.98 $7.58 Million - $8.58 Million	175,113 Added 99.26%	351,538 $15.9 Million
Q2 2025 Aug 14, 2025	BUY	$44.12 - $59.6 $5.14 Million - $6.94 Million	116,510 Added 194.46%	176,425 $8.17 Million
Q1 2025 May 15, 2025	SELL	$53.9 - $63.11 $1.32 Million - $1.54 Million	-24,410 Reduced 28.95%	59,915 $3.65 Million
Q4 2024 Feb 14, 2025	SELL	$51.92 - $59.94 $3.79 Million - $4.37 Million	-72,955 Reduced 46.39%	84,325 $4.77 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $1.57 Million - $2.05 Million	39,597 Added 33.65%	157,280 $8.14 Million

Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $2.11 Million - $2.77 Million	52,357 Added 80.15%	117,683 $4.89 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $1.36 Million - $1.54 Million	-28,312 Reduced 30.24%	65,326 $3.54 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $2.06 Million - $2.46 Million	42,457 Added 82.95%	93,638 $4.8 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.54 Million - $1.72 Million	26,534 Added 107.66%	51,181 $2.97 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.57 Million - $1.74 Million	24,647 New	24,647 $1.58 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1.7 Million - $2.01 Million	24,846 Added 107.26%	48,010 $3.45 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $602 - $356,076	4,634 Added 25.01%	23,164 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $923,871 - $1.02 Million	12,722 Added 219.04%	18,530 $1.43 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $894,841 - $1.07 Million	-14,555 Reduced 71.48%	5,808 $424,000
Q4 2021 May 03, 2022	SELL	$53.63 - $62.52 $1.19 Million - $1.39 Million	-22,200 Reduced 52.16%	20,363 $1.27 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1.52 Million - $1.77 Million	28,372 Added 199.93%	42,563 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $164,551 - $192,751	2,781 Added 24.37%	14,191 $840,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $2.41 Million - $2.62 Million	-38,911 Reduced 77.33%	11,410 $762,000
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $2.62 Million - $2.95 Million	44,154 Added 715.97%	50,321 $3.18 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $22,691 - $25,713	393 Added 6.81%	6,167 $383,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $16,252 - $18,010	-283 Reduced 4.67%	5,774 $348,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $90,343 - $105,620	-1,648 Reduced 21.39%	6,057 $356,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $4.89 Million - $7.11 Million	-105,495 Reduced 93.19%	7,705 $429,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $4.7 Million - $6.13 Million	95,564 Added 541.87%	113,200 $7.27 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $563,954 - $672,446	12,499 Added 243.31%	17,636 $841,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.21 Million - $1.57 Million	-24,834 Reduced 82.86%	5,137 $267,000
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $108,006 - $121,823	-1,957 Reduced 6.13%	29,971 $1.86 Million
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $988,215 - $1.23 Million	19,557 Added 158.09%	31,928 $1.77 Million
Q1 2018 May 16, 2018	SELL	$59.92 - $68.98 $306,550 - $352,901	-5,116 Reduced 29.26%	12,371 $782,000
Q4 2017 Feb 15, 2018	BUY	$59.94 - $65.35 $1.05 Million - $1.14 Million	17,487	17,487 $1.07 Million

Others Institutions Holding BMY

# of Institutions

2,724

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Bristol Myers Squibb CO Transaction History